- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.10. | Chinese Coca Cola rising? A diversifying Eastroc makes second Hong Kong IPO bid | ||
| 16.10. | InnoCare licensing deal flops due to lack of upfront cash | ||
| 15.10. | Nasdaq gets tough on small Chinese IPOs, as an AI-fueled energy storage boom takes off | ||
| 15.10. | BRIEF: Xiaomi SU7 in new fatal accident, shares slump over 5% | ||
| 15.10. | BIT Mining or Solai? A company built on speculation speculates again | ||
| 15.10. | BRIEF: WeRide, Pony AI approved by CSRC to list in Hong Kong | ||
| 15.10. | BRIEF: Shandong Gold profit doubles on surging gold prices | ||
| 14.10. | INDUSTRY BRIEF: Transsion overtakes Vivo in global smartphone market | ||
| 14.10. | BRIEF: Vanke Chairman Xin Jie resigns, citing personal reasons | ||
| 14.10. | EHang tries to break from holding pattern with new longer-range aircraft | ||
| 14.10. | BRIEF: Fibocom to raise up to $373 million in Hong Kong IPO | ||
| 13.10. | Auto stalwart Dongfeng charges up NEV business with Voyah listing plan | ||
| 13.10. | BRIEF: 361 Degrees' main brand sales up 10% in third quarter | ||
| 13.10. | Yangtze Memory overhauls share structure in preparation for IPO | ||
| 13.10. | BRIEF: JST Group launches $267 million Hong Kong IPO | ||
| 10.10. | BRIEF: Zhida shares triple in trading debut after weak pricing | ||
| 10.10. | BRIEF: JL Mag profit rises sharply in first three quarters | ||
| 10.10. | PomDoctor completes U.S. listing ahead of looming Nasdaq crackdown | ||
| 10.10. | Sungrow powers up to meet soaring demand from AI data centers | ||
| 09.10. | BRIEF: JD Logistics to buy two on-demand local delivery units from parent | ||
| 09.10. | Is serving too fast a sin? The Chinese paradox of pre-made foods | ||
| 09.10. | BRIEF: ImmuneOnco to raise $45 million via share placement at 13% discount | ||
| 09.10. | Will Top Toy knock Pop Mart off its throne? | ||
| 09.10. | BRIEF: MedBot reports strong year-to-date sales as commercialization accelerates | ||
| 09.10. | Obesity drug maker Sciwind targets IPO, with heavyweight backers |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .